Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Ruminy

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2016
Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P-Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 CasesSydney Dubois, Pierre-Julien Viailly, Elodie Bohers, et al.
Blood|November 19, 2020
Obinutuzumab vs rituximab for advanced DLBCL: a PET-guided and randomized phase 3 study by LYSASteven Le Gouill, Hervé Ghesquières, Lucie Oberic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2016
Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA StudySydney Dubois, Pierre-Julien Viailly, Sylvain Mareschal, et al.
Blood Advances|October 20, 2023
High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphomaVincent Camus, Pierre-Julien Viailly, Fanny Drieux, et al.
The Journal of Clinical Investigation|November 11, 2014
Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progressionStéphanie Sungalee, Emilie Mamessier, Ester Morgado, et al.
Blood Advances|September 18, 2024
Identification of primary mediastinal B-cell lymphomas with higher clonal dominance and poorer outcome using 5'RACEVincent Camus, Mathieu Viennot, Pierre-Julien Viailly, et al.
Blood Advances|March 3, 2025
Interim PET after 4 cycles predicts outcome in histomolecularly confirmed primary mediastinal B-cell lymphomaVincent Camus, Thierry Molina, Fabienne Desmots, et al.
Blood Advances|April 14, 2026
Interim assessment by circulating tumor DNA in primary mediastinal large B-cell lymphoma: a multicenter LYSA studyVincent Camus, Daphné Krzisch, Alessio Bruscaggin, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2016
Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P-Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 CasesSydney Dubois, Pierre-Julien Viailly, Elodie Bohers, et al.
Blood|November 19, 2020
Obinutuzumab vs rituximab for advanced DLBCL: a PET-guided and randomized phase 3 study by LYSASteven Le Gouill, Hervé Ghesquières, Lucie Oberic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2016
Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA StudySydney Dubois, Pierre-Julien Viailly, Sylvain Mareschal, et al.
Blood Advances|October 20, 2023
High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphomaVincent Camus, Pierre-Julien Viailly, Fanny Drieux, et al.
The Journal of Clinical Investigation|November 11, 2014
Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progressionStéphanie Sungalee, Emilie Mamessier, Ester Morgado, et al.
Blood Advances|September 18, 2024
Identification of primary mediastinal B-cell lymphomas with higher clonal dominance and poorer outcome using 5'RACEVincent Camus, Mathieu Viennot, Pierre-Julien Viailly, et al.
Blood Advances|March 3, 2025
Interim PET after 4 cycles predicts outcome in histomolecularly confirmed primary mediastinal B-cell lymphomaVincent Camus, Thierry Molina, Fabienne Desmots, et al.
Blood Advances|April 14, 2026
Interim assessment by circulating tumor DNA in primary mediastinal large B-cell lymphoma: a multicenter LYSA studyVincent Camus, Daphné Krzisch, Alessio Bruscaggin, et al.
Pageof 9